ALTO NEUROSCIENCE, INC.
Profile
Company Names
ALTO NEUROSCIENCE, INC.
Addresses
650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA 94041
369 SOUTH SAN ANTONIO RD., LOS ALTOS, CA 94022
Phone Numbers
(650) 200-0412
650-200-0412
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, BIOTECHNOLOGY
Year Incorporated:
2019
State Incorporated:
DELAWARE
Total Amount Raised:
$193,870,926.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2025-10-21
$49,999,533.00
$49,999,533.00
$0.00
Equity
4
2023-11-20
$45,000,223.00
$45,000,223.00
$0.00
Equity
3
2022-04-06
$59,261,815.00
$59,261,815.00
$0.00
Equity
2
2021-05-03
$31,887,138.00
$31,887,138.00
$0.00
Equity
1
2019-09-13
$7,722,217.00
$7,722,217.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRIS
DIMITROPOULOS
DIRECTOR
MICHAEL
HANLEY
EXECUTIVE OFFICER
MICHAEL
LIANG
DIRECTOR
PALYON MEDICAL CORP
| PATHCENTRAL, INC.
| VENITI, INC.
| INTEGRATED DIAGNOSTICS, INC.
| INSIGHTRA MEDICAL, INC.
| ZUREX PHARMA, INC.
| AMPHORA MEDICAL, INC.
| ILLINOIS EMERGING TECHNOLOGIES FUND III, LP
| GENOMEDX BIOSCIENCES INC.
| AIC INNOVATIONS GROUP, INC.
| APERVITA, INC.
| GREENLIGHT BIOSCIENCES INC.
| ONCOLOGY ANALYTICS, INC.
| JUMPCODE GENOMICS, INC.
| NEOCHORD INC
| ALTO NEUROSCIENCE, INC.
NICHOLAS
SMITH
EXECUTIVE OFFICER
DSC INVESTMENT PARTNERSHIP I LLC
| FAIRWATER PARTNERS, LLC
| THINKING ENGINES, INC.
| CAMSO HOLDINGS, LLC
| SAILES, INC.
| RPC VENTURES FUND II LP
| VOXTUR ANALYTICS CORP.
| ALTO NEUROSCIENCE, INC.
| LES CO-INVEST I LP
| RPC MSR INVESTMENT FUND II LP - SERIES 1
| RPC MSR SP 1
| VIEW 21 SPV, LP
| RPC MSR SP 2
| RPC MSR INVESTMENT FUND II LP - SERIES 2
AARON
WEAVER
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-11-20
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-05-03
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-04-06
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-09-13
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

